2019 UW Fall Visiting Professor Lectureship - Hip Preservation
Statement of Need
Hip preservation, which includes hip arthroscopy, periacetabular osteotomy, surgical hip dislocation, and femoral derotational osteotomies, is one of the fastest growing fields within orthopaedic surgery. The surgical techniques that we currently utilize have significantly changed our approach to the patient with hip pain. Hip preservation is also one of the most multidisciplinary fields within orthopaedic surgery, requiring significant interplay between pediatric orthopaedics, sports medicine orthopaedics, hip arthroplasty, trauma expertise in pelvic anatomy, and heavy reliance on the contributions of musculoskeletal radiology, physiatry, physical thearapy and pain control modalities. Given the increasing prevalence of hip preservation surgery and its significant reach across disciplines, a visiting professorship dedicated to the topic will increase awareness of the capabilities as well as limitations of hip preservation. The visiting professorship will also facilitiate cross-disciplinary interactions which can maximize treatment effectiveness for the patient with hip pain.
We will engage participants through interactive case discussions, research presentations and targeted lectures on hip preservation, including the indications and limitations of hip preservation surgery.
These educational elements will help providers throughout orthopaedics, rehabilitation, radiology, anestesiology and others gain an understanding of hip preservation.
Intended Audience
Local and regional orthopedic surgeons, advanced practice providers, athletic trainers, nurses, residents, medical students, and physical and occupational therapists whose scope of practice includes diagnoses and treatment of patients considering hip preservation surgery.
Learning Objectives
At the completion of this activity, participants will be able to:
- Identify patients who may or not be candidates for hip preservation surgery; including hip preservation failures
- Discuss treatment options outside of hip preservation surgery
- Describe pain modalities for hip preservation surgery
Elements of Competence
This CME activity has been designed to change learner competence and focuses on the areas of patient care and procedural skills, medical knowledge, and practice-based learning and improvement.
Agenda
AM | |
7:15 | Breakfast and "Meet the VP" |
SESSION 1: Hip Preservation from Pediatrics to Mature Adults | |
7:55 | Introduction and Welcome Andrea Spiker, MD |
Pediatrics Topics (SCFE, Perthes, DDH) | |
8:00 | Management of DDH from Birth to 2 years of Age Kenneth Noonan, MD |
8:20 | DDH Perthes, SCFE in Children Pamela Lang, MD |
8:40 | Periacetabular Osteotomy Surgery: Contemporary Refinements and Future Challenges John Clohisy, MD |
Young Athletes | |
9:10 | PAO Case - Athlete David Goodspeed, MD |
9:25 | Return to Sport After Hip Preservation Andrea Spiker, MD |
9:40 | Return to Sport - PT - Our Protocol for Hip Preservation Patients Joseph Tupta, PT |
10:00 | Hip Preservation Over Age 50 and Revision Hip Preservation Andrea Spiker, MD |
10:15 | Imaging Labral Tears and Pitfalls Donna Blankenbaker, MD |
10:35 | BREAK |
SESSION 2: When Not to Do Hip Preservation? - Session Introduction: David Goodspeed, MD | |
10:50 | Hip Preservation Surgery Failures - What I've Learned Over the Course of My Career David Goodspeed, MD |
11:05 | Endstage Hip Disease in Young Patients: What is the Role of Total Hip Arthroplasty? John Clohisy, MD |
The Interplay of Arthroplasty and Hip Preservation | |
11:35 | Resurfacing Brian Nickel, MD |
11:55 | THA After Prior Hip Preservation Surgery Richard Illgen, MD |
PM | |
12:15 | LUNCH |
1:00 | Hip Pain Treatment Outside of Surgery - Treatment Options for Hip Pain/Post Operative Treatment Options from PM&R Perspective Michelle Poliak-Tunis, MD |
1:20 | Imaging Less Common Impingement Syndromes Donna Blankenbaker, MD |
SESSION 3: Future Directions - Session Introduction - Christopher Whalen, MD | |
1:40 | Diagnostic and Treatment Decision-Making for the Borderline Dysplastic Hip John Clohisy, MD |
2:10 | Application of Hip Preservation Techniques in Trauma Christopher Doro, MD |
Research Future Directions | |
2:25 | Optimizing Cell Therapy for Cartilage Repair and Joint Preservation Brian Walczak, DO |
2:45 | Radiographic Measurements Ryan Graf, MD |
3:10 | Pain Modalities for Hip Patients Outside of Opioids (Including Regional Anesthesia) Kristopher Schroeder, MD |
3:30 | Closing Remarks - Adjourn |
*Terese Bailey, BS; Senior Outreach Specialist, Office of Continuing Professional Development
Donna Blankenbaker, MD; Professor, Department of Surgery
Christopher Doro, MD; Clinical Assistant Professor, Department of Orthopedics and Rehabilitation
*Erica Fry, BA; Student Services Coordinator, Department of Orthopedics and Rehabilitation
*David Goodspeed, MD; Associate Professor, Department of Orthopedics and Rehabilitation
Ryan Graf, MD; Resident, Department of Orthopedics and Rehabilitation
Richard Illgen, MD; Professor, Department of Orthopedics and Rehabilitation
*Delilah Kowalke; Education Program Manager, Department of Orthopedics and Rehabilitation
Pamela Lang, MD; Assistant Professor, Department of Orthopedics and Rehabilitation
Brian Nickel, MD; Assistant Professor, Department of Orthopedics and Rehabilitation
Kenneth Noonan, MD; Associate Professor, Department of Orthopedics and Rehabilitation
Michelle Poliak-Tunis, MD; Assistant Professor, Department of Orthopedics and Rehabilitation
Kristopher Schroeder, MD; Associate Professor, Department of Anesthesiology
Andrea Spiker, MD; Assistant Professor, Department of Orthopedics and Rehabilitation
Joseph Tupta, PT; Physical Therapist, University of Wisconsin Hospital and Clinics
Brian Walczak, DO; Clinical Instructor, Department of Orthopedics and Rehabilitation
Christopher Whalen, MD; Resident, Department of Orthopedic Surgery
*Planning Committee
POLICY ON DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this educational activity, all conflicts of interest have been resolved and detailed disclosures are listed below.
Name | Role | Financial Relationships Disclosure | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
Terese Bailey, BS | Planner | No relevant financial relationships to disclose | No |
Donna Blankenbaker, MD | Presenter | No relevant financial relationships to disclose | No |
John Clohisy, MD | Presenter | Microport, Zimmer Biomet (Consultant); Zimmer Biomet (PI); Microport (Product Royalty); Wolters Kluwer Health (Publication Royalty) | No |
Christopher Doro, MD | Presenter | No relevant financial relationships to disclose | No |
Erica Fry, Ba | Planner | No relevant financial relationships to disclose | No |
David Goodspeed, MD | Planner and Presenter | Depuy Synthes (Consultant) | No |
Ryan Graf, MD | Presenter (Resident) | No relevant financial relationships to disclose | No |
Richard Illgen, MD | Presenter | Mako Surgical, Orthosensor, Stryker Mako (Consultant); Mako Surgical, Orthosensor (Teacher/Speaker) | No |
Delilah Kowalke | Planner | No relevant financial relationships to disclose | No |
Pamela Lang, MD | Presenter | No relevant financial relationships to disclose | No |
Brian Nickel, MD | Presenter | No relevant financial relationships to disclose | No |
Kenneth Noonan, MD | Presenter | No relevant financial relationships to disclose | No |
Michelle Poliak-Tunis, MD | Presenter | No relevant financial relationships to disclose | Yes |
Kristopher Schroeder, MD | Presenter | No relevant financial relationships to disclose | Yes |
Andrea Spiker, MD | Planner, Presenter, and Content Reviewer | No relevant financial relationships to disclose | No |
Joseph Tupta, PT | Presenter | No relevant financial relationships to disclose | No |
Brian Walczak, DO | Presenter | No relevant financial relationships to disclose | No |
Christopher Whalen, MD | Presenter (Resident) | No relevant financial relationships to disclose | No |
*The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
In support of improving patient care, the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement
The University of University of Wisconsin–Madison ICEP designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.65 continuing education units (CEUs) or 6.5 hours.
Available Credit
- 6.50 AMA PRA Category 1 Credit™
- 6.50 University of Wisconsin–Madison Continuing Education Hours